Advertisement
PARIS, France—A biodegradable-polymer drug-eluting stent has proven noninferior to a durable-polymer device in terms of late lumen loss at 9 months,…
PARIS, France—A fully bioresorbable drug-eluting stent (DES) shows low late lumen loss and good safety results at 6 months in patients with de novo…
For patients with bifurcation lesions, the new dual-stent modified “flower petal” technique offers several advantages over available stenting options,…
Compared with standard evaluation, which often includes nothing but observation and discharge, use of coronary computed tomographic angiography (CTA)…
In patients with acute intracranial large-vessel occlusions, endovascular therapy reduces final infarct size more than either intravenous tissue plasminogen…
In patients undergoing transcatheter aortic valve replacement (TAVR), a dual-filter embolic protection device enables the capture of debris traveling…
Oxygen administration prior to elective angiography or percutaneous coronary intervention (PCI) reduces contrast induced nephropathy (CIN), according…
At 4 years, patients with mitral valve regurgitation who undergo repair with a novel percutaneous device experience mortality rates and mitral regurgitation…
In patients undergoing transcatheter aortic valve replacement (TAVR), the need for acute valve-in-valve therapy and the occurrence of embolization…
For patients with nonvalvular atrial fibrillation (A-fib), closing the left atrial appendage (LAA) with the Watchman device is superior to warfarin…
In patients with resistant hypertension, renal denervation substantially reduces blood pressure at 6 months, with the benefit apparent as early as…
Health care providers are doing a poor job putting modern radiation-limiting measures into practice when it comes to nuclear stress testing, and many…